W J Urba Selected Research

W J Urba Research Topics

9	Neoplasms (Cancer) 01/2019 - 02/2000
4	Melanoma (Melanoma, Malignant) 01/2019 - 04/2001
3	Breast Neoplasms (Breast Cancer) 08/2005 - 01/2000
2	Neoplasm Metastasis (Metastasis) 07/2003 - 04/2001
1	Renal Cell Carcinoma (Grawitz Tumor) 04/2001
1	Anemia 04/2001
1	Neutropenia 04/2001
1	Thrombocytopenia (Thrombopenia) 04/2001
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2000
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 05/2000
1	Splenomegaly 05/2000
1	Lymphoma (Lymphomas) 05/2000
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 05/2000
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 02/2000

2	VaccinesIBA 01/2004 - 06/2001
2	Cancer VaccinesIBA 07/2003 - 09/2000
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 06/2001 - 04/2001
1	NivolumabIBA 01/2019
1	Hematoxylin (Haematoxylon)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2005
1	AnthracyclinesIBA 08/2005
1	Docetaxel (Taxotere)FDA Link 08/2005
1	AntigensIBA 01/2004
1	Fas Ligand Protein (Fas Ligand)IBA 06/2001
1	Granzymes (Granzyme)IBA 06/2001
1	PerforinIBA 06/2001
1	Topoisomerase I InhibitorsIBA 04/2001
1	Macrophage Colony-Stimulating FactorIBA 04/2001
1	Topotecan (Hycamtin)FDA LinkGeneric 04/2001
1	Chemokine ReceptorsIBA 02/2001
1	ChemokinesIBA 02/2001
1	Neoplasm Antigens (Tumor Antigens)IBA 09/2000
1	L-SelectinIBA 09/2000
1	CytokinesIBA 09/2000
1	Interleukin-2 (IL2)IBA 09/2000
1	Etoposide (VP 16)FDA LinkGeneric 05/2000
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2000
1	Vincristine (Oncovin)FDA LinkGeneric 05/2000
1	Bleomycin (Blenoxane)FDA LinkGeneric 05/2000
1	Cytarabine (Cytosar-U)FDA LinkGeneric 05/2000
1	Prednisone (Sone)FDA LinkGeneric 05/2000
1	RicinIBA 05/2000
1	Immunotoxins (Immunotoxin)IBA 05/2000
1	Mechlorethamine (Nitrogen Mustard)FDA Link 05/2000
1	Methotrexate (Mexate)FDA LinkGeneric 05/2000
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2000
1	Myelin Basic ProteinIBA 02/2000
1	To autoantigenIBA 02/2000
1	Complementary DNA (cDNA)IBA 01/2000
1	Amino Acids FDA Link 01/2000

4	Immunotherapy 07/2003 - 02/2000
3	Drug Therapy (Chemotherapy) 08/2005 - 05/2000
2	Therapeutics 01/2019 - 05/2000
1	Nephrectomy 04/2001
1	Aftercare (After-Treatment) 10/2000
1	PROMACE-CytaBOM protocol 05/2000
1	Combination Drug Therapy (Combination Chemotherapy) 05/2000
1	Operative Surgical Procedures 05/2000